ARID1A and hepatocellular carcinoma: For instance, a study conducted on hepatocellular carcinoma cell lines uncovered that ARID1A-containing BAF activates and represses roughly equal numbers of genes, while ARID1B-containing BAF was found to primarily repress enhancer activity44.